Skin Barrier and Inflammation Genes Associated with Atopic Dermatitis are Regulated by Interleukin-13 and Modulated by Tralokinumab In vitro

被引:16
|
作者
Tollenaere, Maxim A. X. [1 ]
Litman, Thomas [1 ]
Moebus, Lena [2 ]
Rodriguez, Elke [2 ]
Stoelzl, Dora [2 ]
Drerup, Katharina [2 ]
Werfel, Thomas [3 ]
Schmitt, Jochen [4 ]
Norsgaard, Hanne [1 ]
Weidinger, Stephan [2 ]
机构
[1] LEO Pharma AS, Skin Res, Ballerup, Denmark
[2] Univ Hosp Schleswig Holstein, Dept Dermatol Venereol & Allergol, Campus Kiel, Kiel, Germany
[3] Hannover Med Sch, Dept Dermatol Allergol & Venereol, Div Immunodermatol & Allergy Res, Hannover, Germany
[4] Tech Univ Dresden, Med Fac Carl Gustav Carus, Ctr Evidence Based Hlth Care ZEGV, Dresden, Germany
关键词
D O I
10.2340/00015555-3810
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [31] Interleukin 33 may deteriorate skin barrier function in atopic dermatitis
    Nygaard, U.
    Hvid, M.
    Johansen, C.
    Deleuran, M.
    Vestergaard, C.
    BRITISH JOURNAL OF DERMATOLOGY, 2014, 170 (06) : E26 - E27
  • [32] Dupilumab reduces inflammation and restores the skin barrier in patients with atopic dermatitis
    Rohner, Maria Helena
    Thormann, Kathrin
    Cazzaniga, Simone
    Yousefi, Shida
    Simon, Hans-Uwe
    Schlapbach, Christoph
    Simon, Dagmar
    ALLERGY, 2021, 76 (04) : 1268 - 1270
  • [33] The targeted Action on Interleukin-13 with Tralokinumab improved the Sleep in two randomized, double-blind, placebo-controlled Phase III Studies in Patients with atopic Dermatitis
    Simon, J. C.
    Barbarot, S.
    Gooderham, M.
    Simpson, E.
    Kurbasic, A.
    Olsen, C. K.
    Cork, M. J.
    Silverberg, J., I
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2021, 19 : 56 - 56
  • [34] Specifically targeting interleukin-13 with tralokinumab improved sleep in two phase III, randomized, double-blind, placebo-controlled trials in patients with atopic dermatitis
    Silverberg, J. I.
    Barbarot, S.
    Gooderham, M.
    Simon, J. C.
    Simpson, E.
    Kurbasic, A.
    Olsen, C. K.
    Cork, M. J.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 184 (03) : E64 - E65
  • [35] Topical delivery of interleukin-13 antisense oligonucleotides with cationic elastic liposome for the treatment of atopic dermatitis
    Kim, Sung Tae
    Lee, Kyung-Mi
    Park, Hyun-Joo
    Jin, Su-Eon
    Ahn, Woong Shick
    Kim, Chong-Kook
    JOURNAL OF GENE MEDICINE, 2009, 11 (01): : 26 - 37
  • [36] Enhanced expression levels of interleukin-31 correlate with interleukin-4 and interleukin-13 in atopic and allergic contact dermatitis
    Neis, M. M.
    Peters, B.
    Dreuw, A.
    Bieber, T.
    Krieg, T.
    Stanzel, S.
    Heinrich, P. C.
    Merk, H. F.
    Baron, J. M.
    Hermanns, H. M.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2006, 126 : 59 - 59
  • [37] Tralokinumab, an anti-interleukin-13 monoclonal antibody, reduces Staphylococcus aureus colonization of the skin and systemic levels of inflammatory biomarkers in atopic dermatitis patients
    Guttman-Yassky, Emma
    Silverberg, Jonathan
    Roepke, Mads
    Wollenberg, Andreas
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB139 - AB139
  • [38] Relationship of interleukin-13 and interleukin-33 serum concentration and selected clinical and immunological parameters in patients with atopic dermatitis
    Pszonak, A.
    Owczarek, W.
    Paluchowska, E.
    Olkowska-Truchanowicz, J.
    IMMUNOLOGY, 2012, 137 : 526 - 527
  • [39] Staphylococcus aureus exploits barrier defects in atopic dermatitis to trigger skin inflammation
    Nakatsuji, T.
    Two, A. M.
    Chun, K. A.
    Chen, T. H.
    Geha, R. S.
    Hata, T.
    Gallo, R. L.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2016, 136 (05) : S85 - S85
  • [40] Inflammation-Induced Alterations in the Skin Barrier Function: Implications in Atopic Dermatitis
    Vestergaard, Christian
    Hvid, Malene
    Johansen, Claus
    Kemp, Kaare
    Deleuran, Bent
    Deleuran, Mette
    NEW TRENDS IN ALLERGY AND ATOPIC ECZEMA, 2012, 96 : 77 - 80